Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2018

Renounceable Rights Issue

10 May 2018 by Audrey Thomson

Renounceable Rights Issue

Categories 2018, ASX Announcements

Request for Trading Halt

9 May 2018 by Audrey Thomson

Request for Trading Halt

Categories 2018, ASX Announcements

Quarterly Report 31 March 2018

26 April 2018 by Audrey Thomson

Quarterly Report 31 March 2018

Categories 2018, ASX Announcements, Quarterly Reports

Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial

6 April 2018 by Audrey Thomson

Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial

Categories 2018, ASX Announcements

Half-year Report 31 December 2017

20 February 201920 February 2018 by Audrey Thomson

Half-year Report 31 December 2017

Categories 2018, ASX Announcements, Half-year reports

Quarterly Report 31 December 2017

16 January 2018 by Justine Bednorz

Quarterly Report 31 December 2017

Categories 2018, ASX Announcements, Quarterly Reports

Biotech Showcase 2018 Presentation

10 January 2018 by Audrey Thomson

Biotech Showcase 2018 Presentation

Categories 2018, Corporate Presentations

Biotron Limited Presents at Biotech Showcase 2018

10 January 2018 by Audrey Thomson

Biotron Limited Presents at Biotech Showcase 2018

Categories 2018, ASX Announcements
Newer posts
← Previous Page1 … Page5 Page6
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 12 December 2025        Legal Notices and Privacy
Cleantalk Pixel